Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions.
J Neurol Sci
; 427: 117532, 2021 08 15.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1253235
ABSTRACT
BACKGROUND:
Vaccine induced immune mediated thrombocytopenia or VITT, is a recent and rare phenomenon of thrombosis with thrombocytopenia, frequently including cerebral venous thromboses (CVT), that has been described following vaccination with adenovirus vaccines ChAdOx1 nCOV-19 (AstraZeneca) and Ad26.COV2·S Johnson and Johnson (Janssen/J&J). The evaluation and management of suspected cases of CVT post COVID-19 vaccination are critical skills for a broad range of healthcare providers.METHODS:
A collaborative comprehensive review of literature was conducted among a global group of expert neurologists and hematologists.FINDINGS:
Strategies for rapid evaluation and treatment of the CVT in the context of possible VITT exist, including inflammatory marker measurements, PF4 assays, and non-heparin anticoagulation.Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Thrombose veineuse
/
COVID-19
Type d'étude:
Études expérimentales
/
Étude pronostique
Les sujets:
Covid long
/
Vaccins
Limites du sujet:
Humains
langue:
Anglais
Revue:
J Neurol Sci
Année:
2021
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS